.png)
.png)
Strategy That Survives Contact with Execution
Most commercial strategy work produces frameworks. ISG produces commercial strategies built by people who have actually executed them — designed sales forces, hired marketing leaders, negotiated payer contracts, run launch readiness reviews, and lived with the consequences of the strategic choices made twelve months earlier.
That operational reality changes the work. A strategy that looks elegant in a deck but cannot be staffed, financed, or executed against the company’s actual constraints is not a strategy — it’s an aspiration. ISG works the other way: strategy built backwards from execution, calibrated to the resources and timeline the company actually has, and structured to produce commercial momentum at the points investors and boards measure.
- Brand strategy and positioning grounded in launch experience
- Sales force design, sizing, and deployment
- Marketing, market access, and commercial operations function design
- Launch planning across pre-, during-, and post-launch phases
- Digital medicine, telehealth, and direct-to-patient platform strategy
- Digital medicine, telehealth, and direct-to-patient platform strategy
Outcomes That Define Commercial Success
Commercial strategy work at ISG ladders to the four outcomes that determine whether a launch produces enterprise value or just activity.
Launch Readiness That’s Real
A commercial organization, market access plan, and go-to-market strategy ready to execute on day one of approval — not three months after. Pre-launch infrastructure decisions made early enough to actually shape outcomes.
Commercial Strategy That Maps to Capital Strategy
Strategy built to align with the financing milestones it depends on — so the launch story you tell investors is the launch you can actually execute, and the capital you raise funds the commercial moves that drive the next round.
Differentiated Market Position
Brand positioning and value proposition that resonate with prescribers, payers, and patients — and hold up against the competitive response that always arrives faster than the launch plan assumed.
Commercial Models Built for the Moment
Direct-to-patient infrastructure, digital medicine platforms, telehealth integration, specialty pharmacy strategy — commercial models calibrated to where the patient actually is, not where the org chart of a larger company assumes they are.
How We Approach Commercial Strategy
Methodology informed by 15+ launches and the operational realities of getting therapies and devices to market — calibrated to the constraints early- and growth-stage companies actually face, not the resources large pharma assumes.
01
Commercial Diagnostic
Map current commercial readiness against launch timeline. Identify the gaps in strategy, organization, market access, and capital plan that will determine launch success.
02
Strategy Development
Build the integrated commercial strategy: positioning, channel, organization design, market access, launch sequencing, and the digital and direct-to-patient infrastructure the model requires.
03
Organizational Design
Define the commercial organization needed for launch — sizing, role definition, hiring sequence, and the external partnerships that compress the build timeline.
04
Launch Execution Support
Embedded support through launch — operational reviews, course correction, hiring decisions, and the board and investor communications that connect commercial performance to the capital story.
05
Post-Launch Optimization
Performance review and strategy refinement based on early launch data — adjusting channel, message, organization, and resource allocation against what the market is actually telling you.
Where Commercial Strategy Engagements Concentrate
Core strategic pillars that drive successful commercialization and long-term market success.
- Brand & Positioning
- Therapeutic area positioning and value proposition development
- Competitive positioning and differentiated messaging
- HCP, patient, and payer messaging architecture
- Commercial Organization Design
- Sales force sizing and deployment
- Marketing, market access, and commercial operations function design
- Hiring sequence and external partnership strategy
- Launch Planning
- Launch sequencing across geographies and indications
- Pre-launch infrastructure build
- Launch readiness assessment and gap closure
- Digital Medicine & Direct-to-Patient
- Digital medicine platform strategy and build
- Telehealth integration and direct-to-patient infrastructure
- Patient engagement and adherence programs
- Market Access Integration
- Payer strategy and pricing model alignment
- Specialty pharmacy and distribution strategy
- Reimbursement strategy across channels
- Commercial Performance Management
- P&L design and management
- Commercial KPIs and board-level reporting
- Performance review and course correction
Companies This Engagement Is Built For
.png)
Pre-Commercial Biotech & Medical Device Companies
Companies 12–24 months from launch building commercial infrastructure for the first time, where the strategic choices made now will determine launch outcomes.
.png)
Companies Launching First Commercial Asset
Companies transitioning from clinical to commercial — building first-time sales, marketing, market access, and digital infrastructure where no internal template exists.
.png)
Specialty & Rare Disease Companies
Companies launching specialty therapies where commercial model design — direct-to-patient, specialty pharmacy, digital medicine — materially shapes outcomes.
Companies Scaling Post-Launch
Companies 6–18 months post-launch optimizing commercial execution against early performance data, refining channel mix, and scaling what’s working.
Related Engagements
MedNova Technologies
A premium website redesign focused on user engagement, visual storytelling, and scalable financial communication.
150+
Commercial team built
$100M+
P&L managed
First-in-Class
Product launched
.png)
Ready to Build the Commercial Strategy?
Every commercial strategy engagement starts with a diagnostic conversation about where you are, what the launch requires, and the strategic choices that will determine outcomes.